This study demonstrates the possibility of achieving a prophylactic effect by intramuscular injection of Abies sibirica polyprenols for the control of influenza virus infection in mice. One of the five polyprenol preparations tested, preparation N1, which had the lowest hydrophilic-lipophilic balance (8.6), produced a significant protective effect when injected in a dose of 2000 µg/mouse 2 days before aerosol infection of mice with influenza virus. A moderate protective effect was also observed using a second preparation, designated N2. One day after aerosol infection, animals pre-treated with 2000 µg doses of the polyprenol preparations or Hanks' solution showed no difference in the level of interferon accumulation in the lungs. Three days after injection of preparation N2 and N1, a significant decrease in spleen and thymus weights was observed in the mice. One day after injection of these preparations, the number of lymphocytes in the bronchoalveolar tract of the mice exceeded almost twice that seen in mice treated with place-
Introduction
In experiments with synthetic 2,3-dihydroheptaprenol, a prophylactic effect was achieved against a generalized colibacterial infection in mice (Araki et al., 1987) , and increased resistance to Staphylococcus aureus, Klebsiella pneumoniae and Pseudomonas aeruginosa was observed in animals treated with this compound. This effect appeared to be caused by non-specific activation of the cells of the reticuloendothelial system. In subsequent studies, positive results were also obtained from the prophylactic use of 2, 3-dihydroheptaprenol in mice infected with Sendai virus (Iida et al., 1990) . These later data suggest that the preparation's protective effect may also be associated with increased interferon levels in the infected animals' lungs. Raldugin et al. (1996) isolated polyprenol from the needles of Siberian fir (Abies sibirica Ledb.) by adsorption chromatography on silica gel. The preparation, purified up to 95% (by NMR spectra) has been shown to be a mixture of isoprenologs with a common formula shown in Figure 1 .
This study sought to evaluate the prophylactic efficacy of these polyprenol preparations on an experimentally induced influenza virus infection in mice, and to elucidate the important immunological factors associated with the protection seen. The factors evaluated included interferon induction, thymus and spleen weights, number and functional activity of phagocytes of the bronchoalveolar tract. All these immunological effects are influenced by influenza virus infection and immunomodulators (Pyankova et al., 1997; Shishkina et al., 1999; Dyer et al., 1994) .
Materials and Methods

Virus
Influenza virus A/Aichi/2/68 (H3N2) was obtained from the Moscow Ivanovsky Institute of Virology. The virus was passaged 12 times in mice and twice in embryonated chicken eggs (ECE). Allantoic fluid produced by cultivating the virus in 9-11-day-old ECE with a viral concentration of 10 8 -10 9 50% embryonic infecting doses (EID 50 ) per ml was used in these experiments. Encephalomyocarditis virus (Columbia strain, obtained from Moscow Ivanovsky Institute of Virology) was used to determine interferon activity.
Animals
Outbred albino male and female mice weighing 15-17 g were used. The animals were reared from a colony maintained at this facility.
Polyprenol preparations
Emulsive preparative forms of polyprenol from Abies sibirica stabilized with egg lecithin (purified, ICN) and non-ionic surface active agents (SAA) referring to ethers of fatty acids with polyethylene glycol or polyatomic alcohols (sorbitol) (SERVA, Germany) were prepared for these experiments.
To produce the emulsions, polyprenol solutions (in hexane or petroleum ether) and emulsifiers (lecithin in chloroform or non-ionic SAA in ethanol) were mixed after warming to 40-50 0 C, evaporated and dried as a thin film on a rotary evaporator. They were then re-evaporated to remove the remaining aprotic solvent and dissolved in ethanol (by selecting compositions of emulsifiers that allowed the production of transparent alcohol solutions). Emulsions were then formed by injecting alcohol solution into water warmed to 40-60 0 C and surplus ethanol was removed to provide a residual ethanol content of not more than 10%. Compositions of emulsifiers in the absence of polyprenols were used as control preparations in a number of experiments; in the antiviral experiments Hanks' solution was used as placebo.
Turbidity of the emulsions and the turbidimetrical parameter P (Slonim, 1960) , determined by turbidity spectra A(λ) (at the wave length λ in the range of 400-650 nm), were evaluated by interpolation according to the formula: logA(λ) = C -P . log(λ) where C is a constant. Smaller P values correspond to larger micelles of the emulsion. The effective hydrophiliclipophilic balance (HLB) value of compositions of emulsifiers a and b were calculated according to the formula (Gizurarson et al., 1995) :
where C a and C b are concentrations of the a and b components. All the preparations were stored at 4-6°C before use.
Aerosol studies
These studies were performed in a small dynamic chamber (SDC) at 50-70% relative humidity and a temperature of 20-24°C. The basic characteristics of the chamber and the aerosol equipment used has been described previously (Sergeyev et al., 1999) . The chamber allowed the infection of 20 mice at a time. Aerosol flow rate in the exposure channel was 10 cm/s, and the time-period of aerosol flow passing through the whole chamber was 5-7 s.
Glycerol (10% of the volume) was added to the viruscontaining suspension in all aerosol experiments. The infectious material was administered using a pneumatic biological aerosol generator (BG-2) that produced an ©2000 International Medical Press aerosol with a median mass aerodynamic diameter of 1.1 µm (σ g =2.1). The range of particle dimensions of the aerosols was determined with a 4-cascade impactor BP-35/25-4. The impactor was pre-calibrated with monodispersed aerosol particles. To trap particles with an aerodynamic diameter of less than 0.8 µm, the impactor outlet was connected with AFA-BA filter (Sergeyev et al., 1999) .
The viral aerosol was diluted with an aerosol doser by changing the outlet orifice from 0.5 to 6 mm. Aerosol samples were collected into microcyclones (MC-2) pre-filled with 10 ml of adsorbing fluid, which consisted of Hanks' solution containing 2% (of the volume) of inactivated bovine serum, 100 U/ml of penicillin and 100 g/ml of streptomycin. The volumetric sampling rate was 10.0±0.5 l/min.
The virus concentrations in microcyclone samples and in the initial virus-containing suspension were determined by titration in 9-11-day-old ECE inoculated with the material at 0.1 ml into the allantoic cavity.
The exposure dose used in the aerosol activity study in mice was determined by the formula (Gapochko et al., 1983 ) DE=CTV where C is the virus biological concentration in aerosol (log 10 EID 50 /l), T is the period of the animal's exposure (min) and V is the amount of air inhaled by the animals within 1 min (l/min), calculated by the formula described by Guyton (1947) .
The specificity of the experimental animals' death was determined by haemagglutination activity of allantoic fluid collected from ECE inoculated with suspensions of homogenates of the dying animals' lungs.
Immunological characteristics
The interferon concentration was determined in the animals' serum and lungs (five animals in both the experimental and control groups) 1 day after infection, according to a previously described method (Bulychev et al., 1998) . The lungs were removed under sterile conditions, homogenized and the homogenate was suspended in 1.5 ml of Hanks' solution containing 100 U/ml of penicillin, 100 µg/ml of streptomycin and 20 U/ml of heparin. The samples were incubated at 4ºC for 1 h; then the soluble portion was separated from the cell debris and the intact tissue pieces by low-speed centrifugation. Each well of 24-well polystyrene panels was filled with 0.8 ml of medium and 0.2 ml of the sample. Virus inactivation was carried out following a previously described method (Iida et al., 1990) , by placing the panels at a distance of 30 cm from a 15 Watt UV lamp for 20 min. The degree of virus inactivation was determined by titration in ECE.
Interferon concentration in the test samples was determined by titration in L-929 cells in 96-well polystyrene panels (Ershov & Sayitkulov, 1984) . A value reciprocal to an interferon final dilution providing 50% protection of cells against 100 TCD 50 of the test virus was considered the unit of measurement for interferon activity.
One and 3 days after intramuscular (i.m.) injection of polyprenol preparations N1 and N2 and their control samples, the following indices were evaluated: renal indices (RI) of thymus and spleen (relation of thymus and spleen weights to kidney weight); number (N) of cells of bronchoalveolar tract (BAT) [percentage (%) and absolute number (N) of macrophages (Mph), lymphocytes (Lph) and neutrophils (Nph) in BAT]; indices of superoxide radical anions production, and phagocytic activity of BAT Mph and Nph . To determine these indices in mice, BAT were washed by the method described by Shishkina et al. (1998) , and monolayers of adhesive cells were obtained in microchambers specially mounted on cover glasses for the incubation of 0.1×10 6 cells for 1 h in 0.2 ml of Eagle's MEM supplemented with 10% of serum. Then, the obtained monolayers were incubated with neopsonized zymozan granules (ZG) (d=4 µm, NPO 'Biochemreagent', Riga, Latvia) with 100 particles per cell for 1 h in 0.2 ml of the medium. The monolayers were then rinsed and 0.2 ml of 0.04% nitroblue tetrazolium solution (NTB, Chemapol, Czechoslovakia) was added in colourless Hanks' solution followed by further incubation for 30 min at 37°C.
Incubation with NTB was used to evaluate the production of superoxide radical anions (RA) that reduce NTB to non-soluble diformazan though manifesting oxidizing properties in reactions with other substances (Kolosova & Shishkina, 1989) .
After incubation with NTB the chambers were removed, identical monolayers were fixed, then stained according to Papenheim or with carmine and the following indices were evaluated by microscopy: the number (n) of phagocytized ZG (nZG) per 100 Mph, specific phagocytic activity (SPA) of BAT Mph=(nZG/100 Mph) • N BAT Mph, the number of diformazan-positive ZG (nd .
The prophylactic effect of polyprenol preparation on influenza virus infection was estimated by the resistance index (RI): RI=log 10 ALD 50 (experiment)-log 10 ALD 50 (control) in which 50% aerogenic lethal doses (ALD 50 ) were calculated using the modified Spirman-Kerber's method (Ashmarin & Vorobyov, 1962) using exposure dose values. Experimental results were subjected to statistical data pro-cessing following methods described by Ashmarin & Vorobyov (1962) .
Results
As a result of preliminary physico-chemical studies of various compositions of emulsions, five variants of preparations with a concentration of Abies sibirica polyprenols of 10 mg/ml were selected, which provided acceptable stability of emulsions and variation within a certain range of micelle sizes and HLB (in order to manipulate bio-pharmaceutical characteristics):
N1 As an initial step, experiments were conducted in mice to determine the toxic activity of these preparations. Each was injected i.m. once at doses of 2000 µg or lower, using dilutions in Hanks' solution. The treated animals were observed for 10 days with none of the polyprenol preparations causing signs of toxic effects.
The prophylactic activity of the five variants of the polyprenol preparations on an influenza virus infection was then determined. The animals were injected i.m. with 0.1 ml of each preparation (1000 µg/mouse) or Hanks' solution 2 days before infection with the virus. The mice were infected by aerosol using five animals per dose with four varying viral challenge doses.
This study showed that only the polyprenol preparation N1 produced a significant prophylactic effect (Table 1) . In this case, the resistance index, utilizing the ALD 50 values of N1 and of the control, was 0.67±0.63. A mild prophylactic effect was also seen using preparation N2, but this effect was not statistically significant.
Studies of interferon accumulation levels in the blood and lungs of infected mice 3 days after treatment with the preparations were performed. The animals were infected with influenza virus at the dose of 10 ALD 50 , 2 days after injection of each of the polyprenol preparations. As virus controls, mice were treated with Hanks' solution and subsequently infected with influenza virus; as toxicity controls, uninfected animals were treated with these preparations. It was determined that interferon concentrations in the lungs 1 day after infection did not differ from those in the virus control; the mean values were 20-40 units in 0.2 ml. The uninfected animals treated with polyprenol preparations displayed no detectable interferon in the lungs. Interferon was not detected in the serum of any of the mice.
The polyprenol preparations N1 and N2 were used in subsequent experiments to study their effect on various immune cells in the mice. One and 3 days after i.m. injection of 1000 µg/mouse, the following were evaluated: (i) thymus and spleen RI; (ii) number of BAT cells; (iii) percentage and absolute number of the types of BAT cells; (iv) superoxide radical anions production index of BAT Mph and Nph; and (v) Nph in absorbing zymozan granules. Table 2 presents the thymus and spleen RI data. One day after i.m. injection of both preparations, thymus RI did not differ from the control values. Three days after injection of preparations N1 and N2, thymus RI significantly decreased with respect to the control indices, which is indicative of a decreased weight of this organ in the treated mice. One day after i.m. injection of preparation N2, the spleens did not differ from the control, whereas in the group of animals treated with preparation N1, the spleen RI values were significantly lower than in the control and in the group of mice treated with preparation N2. Three days after i.m. injection of preparations N1 and N2, spleen RI values were significantly lower than the values in Antiviral Chemistry & Chemotherapy 11:3 5 80.5 ± 2.5 14.7 ± 1.4 3.7 ± 1.2 C 85.4 ± 2.4 11.5 ± 1.2 2.9 ± 1.1 N ( 10 3 ) N 1 703 ± 35** 140 ± 7** 32 ± 3 877 ± 46** C 499 ± 26 60 ± 3 13 ± 1 572 ± 43 N2 624 ± 39 114 ± 9** 29 ± 2 775 ± 43** C 485 ± 22 62 ± 10 13 ± 5 525 ± 32 3 % N1 53.5 ± 2.2** 35.0 ± 3.1** 10.5 ± 0.9** C 72.3 ± 3.3 22.8 ± 2.4 5.0 ± 0.9 N2 52.0 ± 3.8** 42.0 ± 3.8** 6.0 ± 0.9 C 71.9 ± 3.6 20.8 ± 2.7 4.3 ± 1.2 N (10   3   ) N 1 269 ± 12** 176 ± 13** 58 ± 5** 503 ± 17 C 325 ± 15 103 ± 8 23 ± 2 450 ± 24 N2 243 ± 12** 196 ± 14** 28 ± 2 467 ± 18 C 322 ± 22 98 ± 11 20 ± 6 437 ± 23 Table 3 . Percentage, absolute (N) and total numbers of cells in the murine bronchoalveolar tract 1 and 3 days after i.m. injection* of preparations N1 and N2 and the corresponding controls (C) the control, which is indicative of a decreased weight of the spleen of mice treated with preparations N1 and N2. Table 3 shows the BAT cell data. One day after injecting mice with preparations of N1 and N2, the number of BAT cells exceeded almost twice the number of BAT cells in the controls. Three days after injection of the preparations, the number of BAT cells sharply decreased compared with those seen on day 1. The cell numbers in the treated groups at this time were within the limits of the concomitant control values.
One day after injection of preparations N1 and N2, the percentages of Mph, Lph and Nph were within the control limits, whereas the absolute number of Mph at day 1 was significantly higher than the control value. The absolute number of Lph also significantly increased compared with the control. By 3 days after injection, however, relative and absolute numbers of Mph decreased, whereas those of Lph significantly increased. The Nph numbers also increased on both days 1 and 3 in animals receiving either N1 or N2; by day 3, these values were statistically higher than in the controls.
As shown in Table 4 , 1 day after i.m. injection of preparations N1 and N2, the phagocytic activity of BAT Mph did not differ from the controls. However, 3 days after injection of these preparations the Mph became almost twice as active in absorbing ZG as compared with injection of the control preparations, indicating each preparation was an effective stimulator of the absorbing ability of BAT Mph. Table 5 shows the results of the determination of superoxide radical anion production indices (RAPI) by BAT Mph after treatment with preparations N1 and N2. One day after i.m. injection of preparation N2, the RAPI did not differ from the control, whereas the same time after injection of preparation N1, RAPI was three times higher (P<0.05) than in the corresponding control. Three days after injection of both preparations N1 and N2, RAPI considerably exceeded control indices, preparation N1 stimulating the radical anion production by five times and preparation N2 by only three times compared with controls. One day after i.m. injection of preparation N2, the specific radical anion production (SRAP) value for all BAT Mph did not differ from the control level, whereas this value in animals receiving preparation N1 exceeded the control values and the values seen after injection of preparation N2 by almost five times (P<0.05). On day 3 after i.m. injection of preparation N2, the SRAP for BAT Mph was almost twice as high as the control and the previous period of study (day 1). The SRAP for BAT Mph on day 3 following injection of preparation N1 significantly exceeded the value seen in mice receiving preparation N2 as well as the control level, but decreased in comparison with what was seen on day 1.
Discussion
In our experiments, on the study of the prophylactic effect of Abies sibirica polyprenols, the administration scheme and the preparations doses were selected that showed the best results in the application of a lecithin emulsion of dolichol (dihydroheptaprenol) used in a colibacterial infection in mice (Araki et al., 1987) . In comparison with results previously obtained using an Escherichia coli infection (Araki et al., 1987) , a reliable prophylactic effect was achieved in the present study using i.m. administration of the lecithin micro-emulsion variant of polyprenol designated preparation N2. The observed lower antiviral activity of this preparation can be accounted for based on the lower biological activity of polyprenols compared with dolichols, which make up only a small percentage of the summary Abies sibirica polyprenols (Grigoryeva & Moiseenkov, 1989) . However, basic differences in pathological mechanisms of AS Safatov et al.
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©2000 International Medical Press influenza virus infection and colibacteriosis in mice may be a more probable explanation for the differences seen, since influenza virus primarily causes lung infection (Pyankova et al., 1997) and E. coli bacterium induces a generalized infection. Negative data similar to those obtained in the present study following the injection of lecithin microemulsion have also been obtained by other researchers (Iida et al., 1990) in experiments with mice that were infected intranasally with Sendai virus. The clinical characteristics of Sendai and influenza virus infections in mice are similar, thus the similarity of the patterns of the polyprenols' antiviral action may be expected. It was important that only one preparation (N1), of all the tested preparations with the same polyprenol concentration, reliably increased the animals' resistance to viral infection, although a moderately positive effect was also observed using preparation N2. Such differences in the protective effects of these tested preparations may be accounted for by the differences in composition and physico-chemical characteristics of the preparations, as well as possible differences in the pharmacokinetics of the material evaluated.
Analysis of the biophysical mechanisms of the polyprenol's pharmacological effects indicates a similar relationship between biological activities and emulsion properties of the polyprenol emulsions and emulsive adjuvants (for example, incomplete Freund's adjuvant). In oily adjuvants, production of finer emulsions by the use of emulsifiers with high HLB resulted in weaker adjuvant properties (Spier & Griffiths, 1985) . This is due to more rapid penetration of small micelles into the systemic circulation and decreased interaction between hydrophilic micelles and macrophages. Preparation N1 had the lowest HLB (8.6) and the largest micelle sizes among all the polyprenol emulsions. In emulsive adjuvants based on nonionic SAA (Gizurarson et al., 1995) , maximal levels of serum antibodies were registered at HLB of around 9. In this experiment, both decreased micelle size (increased P) and increased HLB appeared to weaken the emulsion's antiviral effect. These regularities conform well with the supposed mechanism of non-specific activation of the macrophagal immunity system.
The preparations used in this study did not induce interferon production in the murine blood and lungs such as that seen in the study of other synthetic polyprenol preparations (Iida et al., 1990) . In the present experiment, 1 day after virus exposure, considerable levels of interferon, obviously induced by influenza virus replication, were found in the lungs of the mice, but no significant difference was seen between these concentrations and those obtained in placebo. No interferon was detected in the serum of any group of infected mice. These data suggest that prophylactic injection of preparation N1 in these experiments is not associated with interferon stimulation. However, some researchers (Iida et al., 1990) have recorded a higher interferon level in the lungs of mice infected with Sendai virus after intranasal administration of dihydroheptaprenol compared with that of infected untreated animals. The differences between our results and those cited by others may be explained by differences in the isoprenoids used and methods of administration to the animals.
Decreased relative weights of thymus and spleen following administration of preparation N1 can be indicative of a more intense lymphocyte migration to the other tissues and organs, particularly to the lungs, which might have resulted in the increased number of lymphocytes in the bronchoalveolar tract detected by our experiments.
These studies show that preparation N1 affects macrophage activity (tested as superoxide radical anion production) more actively than preparation N2. After i.m. Table 5 . Radical anions production index (RAPI) and specific radical anions production (SRAP) by macrophages of the murine bronchoalveolar tract 1 and 3 days after i.m. injection* of preparations N1 and N2 and the corresponding controls (C) RAPI (c.u injection of preparation N1, radical anion production by all the macrophages of the murine bronchoalveolar tract was significantly higher on day 1 than that achieved on day 3. Dyer et al. (1994) have shown that influenza virus itself inhibits superoxide anion production in phagocytes, which could substantially contribute to influenza virus pathogenesis. Preliminary prophylaxis increased the ability of macrophages of the lungs to produce active oxygen forms; this may have contributed to the increase in the resistance of the mice to infection by influenza virus before challenge. This result does not conflict with the data of Sidwell et al. (1996) , who showed that after challenge with low doses of influenza virus (75% LD 50 ), survival of mice is favourably influenced by the use of superoxide dismutase, which serves as a trap for free oxygen radicals and decreases their destructive effect on cells in the inflammation zone. It is very likely that this is the way the stabilizing and antiinflammatory activities of superoxide dismutases manifest themselves at the peak moment in the infectious process. However, at the initial moment of infection, a certain increase in the superoxide-producing potential of phagocytes may be more favourable for the host. Since the influenza virus induces an infection in the respiratory tract, it is possible that aerosol administration of these polyprenols may enhance the antiviral efficacy seen. Work is now underway to investigate this route of treatment.
